Rapid testing system designed for emergency and urgent care departments. Provides immediate results for critical blood parameters and biomarkers.
Manufactured by
Shenzhen, Guangdong, China
Located in Shenzhen, China, Dymind Biotechnology Co., Ltd. is a national-level high-tech enterprise specialized in the R D, manufacture, sales and service of medical devices and reagents in the field of in-vitro diagnosis. Dymind is an enterprise driven by innovation, the number of R D staff accounts for over 40%, the annual R D expenditure exceeds 20% of revenue. Dymind has a national-level blood cells reference measurement laboratory approved by CNAS. Dymind has applied for more than 500 national-level patents since establishment and all products have been approved by the international authority quality management system. As a doctoral workstation of Guangdong Province, Dymind established a series of school-enterprise scientific research and training bases with Shenzhen University and Southern Medical University. As a innovator of joint detection of blood routine item and specific protein, Dymind launched its self-developed joint detection analyzers, including blood routine and CRP joint detection analyzers, the world's leading 5-Part and 3-Part joint detection hematology analyzers, automatic blood routine and CRP joint detection analyzers consuming less blood sample and joint detection analyzers for blood routine, CRP and SAA, which promote the new breakthrough of hematology analysis equipment, and further improve the diagnosis and treatment efficiency of medical institutions. Dymind always implements the concept of customer-focused, takes the customer demands as the highest purpose. In Dymind, the products quality is strictly controlled thorough the whole process of manufacturing, the product line is expanded rapidly. In the competition with the domestic brands, Dymind holds an increasing market share, which steady ranks second in the blood testing market. Nowadays, Dymind's products and service have been spread over 120 countries and regions around the world. Through increasingly sophisticated joint detection solutions and high quality products and services for clinical diagnosis, Dymind is always taking care of health with medical innovation.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Response Biomedical
Canada · 2 relevant products
Shenzhen YHLO Biotech Co., Ltd.
China · 1 relevant product
Hangzhou Fanttest Biotech Co., Ltd.
China · 1 relevant product
Fepod Oy Ltd
Finland · 1 relevant product
Biomerica, Inc.
United States · 2 relevant products
Corelax UK Ltd
United Kingdom · 1 relevant product
Eaglenos Sciences, Inc.
China · 1 relevant product
ARPI, Inc
South Korea · 1 relevant product
BioTeke Corporation(wuxi) Co.,Ltd
China · 1 relevant product
IDNEO TECHNOLOGIES S.A.U.
Spain · 1 relevant product
44 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 62 closest product alternatives
Response Biomedical · Canada
Integrated point of care testing platform designed for rapid diagnostic analysis in clinical environments, supporting multiple biomarker assays for immediate patient assessment and decision-making.
Shenzhen YHLO Biotech Co., Ltd. · China
An integrated biochemistry testing platform for clinical laboratory diagnostics. The system encompasses multiple biochemical assays approved for clinical use in patient sample analysis.
Hangzhou Fanttest Biotech Co., Ltd. · China
Comprehensive rapid testing platform for multiple disease detection including respiratory and tropical infectious diseases. The platform supports versatile in vitro diagnostic applications across healthcare settings.
Fepod Oy Ltd · Finland
An integrated portable platform combining mobile phone technology, a pocket-sized reader, and disposable test strips for rapid fingerprick-based diagnostics in acute care settings. Designed for emergency medicine, toxicology, and critical care with results available in minutes.
Biomerica, Inc. · United States
A point-of-care diagnostic platform supporting manual to high-throughput ELISA testing with easy automation capabilities. Enables laboratory-accurate results at the point-of-care.
Corelax UK Ltd · United Kingdom
Advanced point-of-care testing system developed through extensive research and development in diagnostic technologies. Designed for accurate healthcare diagnostic services in clinical settings.
Eaglenos Sciences, Inc. · China
Point-of-care testing system for rapid, accurate detection and personalized health assessment. Integrates precision detection technology with health management protocols for decentralized diagnostic applications.
ARPI, Inc · South Korea
Platform that evaluates ECG data to identify critical cardiac conditions including shock, respiratory distress, cardiac arrest, and severe electrolyte imbalances requiring emergency intervention. Delivers analysis results in real-time for emergency transport scenarios.
BioTeke Corporation(wuxi) Co.,Ltd · China
General rapid testing platform for pathogen antigen or antibody detection with quick result generation. Enables point-of-care clinical decision-making in healthcare settings.
IDNEO TECHNOLOGIES S.A.U. · Spain
Point of Care diagnostic platform enabling real-time patient testing and monitoring at the bedside or clinical setting. Delivers rapid results to support immediate clinical decision-making and patient management across acute and primary care environments.
Innobiochips SAS · France
Automated diagnostic platform for comprehensive transfusion blood safety testing. Integrates multiple testing capabilities including typing, phenotyping, and antibody detection.
Suzhou Molarray Co., Ltd. · China
A point-of-care testing platform for rapid molecular diagnostics at the site of patient care. The system enables quick detection of pathogens and genetic markers without requiring centralized laboratory infrastructure.
50 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products